Dake, Michael D.
O’Sullivan, Gerard
Shammas, Nicolas W.
Lichtenberg, Michael
Mwipatayi, Bibombe P.
Settlage, Richard A.
,
Article History
Received: 19 August 2021
Accepted: 11 September 2021
First Online: 20 September 2021
Change Date: 19 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00270-021-02982-3
Declarations
:
: MDD is a member of the Scientific Advisory Board of W.L. Gore and consultant to Cook Medical. GO is a consultant and received speaker honoraria from Cook Medical, C. R. Bard (Bard)/Becton, Dickinson and Company (BD), Boston Scientific, Philips, Medtronic, WhiteSwell, VeinWay, and Vivasure as well as a shareholder in Marvao Medical. NWS has received research and educational grants from Bard/BD, Boston Scientific, Phillips, AngioDynamics, and VentureMed Group, is on the advisory board of VentureMed group and CSI, and has received speaker honoraria from Janssen, Boehringer Ingelheim, Lilly, Kiniksa, Amgen, and Esperion. ML has received research grants and speaker honoraria from Bard/BD. BPM has received research and educational grants from Boston Scientific, Getinge, and Medtronic Australia as well as speaker honoraria from Bard/BD, Boston Scientific, Getinge, Gore, and Medtronic Australia. RAS is an employee and shareholder of Becton, Dickinson and Company.
: Consent for publication was obtained as part of the written informed consent. All patients consented to publication of the study results if their identity remained confidential.
: All procedures performed on human participants were done in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.